{"database": "lobbying", "table": "lobbying_activities", "rows": [[1960165, "d1bb8e6e-de08-44e2-9890-3ed4c6d9929c", "Q1", "KING & SPALDING LLP", 21632, "U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM", 2017, "first_quarter", "TOR", "Provisions in the Food, Drug & Cosmetic Act related to advertising involving drugs", "Congressional Budget Office (CBO)", null, null, 0, 0, "2017-04-19T12:49:29.610000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1960165"], "units": {}, "query_ms": 0.40610204450786114, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}